Literature DB >> 2976630

Quantitative analysis of a new marker for common acute lymphoblastic leukemia detected by two-dimensional electrophoresis.

S M Hanash1, R Kuick, D Nichols, L Stoolman.   

Abstract

A major subtype of childhood lymphoblastic leukemia has been previously defined on the basis of expression of a cell surface marker referred to as the common acute lymphoblastic leukemia antigen. In this study we provide evidence that leukemic cells from most of the patients with common acute lymphoblastic leukemia contain a cytosolic polypeptide designated L4, the occurrence of which is strongly correlated with the expression of the common acute lymphoblastic leukemia antigen. The detection and quantitation of L4 was accomplished by analysis of cellular polypeptides resolved by two-dimensional polyacrylamide gel electrophoresis. This approach provides a powerful tool for the delineation of distinct polypeptides corresponding to different types of leukemia and complements immunological analysis of the cell surface marker phenotype.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976630

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  3 in total

1.  Highly resolving two-dimensional gels for protein sequencing.

Authors:  S M Hanash; J R Strahler; J V Neel; N Hailat; R Melhem; D Keim; X X Zhu; D Wagner; D A Gage; J T Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins.

Authors:  J R Strahler; R Kuick; C Eckerskorn; F Lottspeich; B C Richardson; D A Fox; L M Stoolman; C A Hanson; D Nichols; H J Tueche
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas.

Authors:  O S Soldes; R D Kuick; I A Thompson; S J Hughes; M B Orringer; M D Iannettoni; S M Hanash; D G Beer
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.